Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist
| Products/Services Used |
Details |
Operation |
| Catalog Antibody> |
/GDMM/CHA/2013 and strain O/MAY98/BY/2010 were optimized and synthesized by GenScript (Nanjing, China |
Get A Quote |